Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28187279.
- Also identified by DOI 10.1016/j.cell.2017.01.030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Curative therapies are most successful when cancer is diagnosed and treated at an early stage. We advocate that technological advances in next-generation sequencing of circulating, tumor-derived nucleic acids hold promise for addressing the challenge of developing safe and effective cancer screening tests.
Medical subject headings
- DNA
- High-Throughput Nucleotide Sequencing
- Neoplasms
- Sequence Analysis, DNA